How Drug Companies are Turning Us All into Patients
Elsewhere US$29.99 US$19.09 Save US$10.90 (36%)
Eligible for Free Shipping Worldwide
Buy in the next 24 hours, we ship tomorrow
Order now for Christmas delivery
|Format:||Paperback, 272 pages|
|Published In: ||Australia, 01 June 2005|
Thirty years ago, the head of Merck, one of the world's best-known drug companies, made some remarkably candid comments. Suggesting he would like his company to be more like chewing gum maker Wrigley's, Henry Gadsen told Fortune magazine it had long been his dream to make drugs for healthy people - so that Merck could 'sell to everyone'. Gadsen's dream now drives the marketing machinery of the most profitable industry on earth. Using their dominating influence in the world of medical science, drug companies are systematically working to widen the very boundaries that define illness. Old conditions are expanded, new ones created, and the markets for medication grow ever larger. Mild problems are redefined as serious illness and common complaints are labelled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMT has become a psychiatric disorder, and hyperactive children have ADD. When it comes to conditions like high cholesterol or low bone density, being 'at risk' is sold as a disease in its own right. Selling Sickness reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt national healthcare systems all over the world. As more and more ordinary life becomes medicalised, the industry moves ever closer to Gadsen's dream: 'selling to everyone'.
Table of Contents
Prologue1. Selling to everyone - High cholestorol2. Donuts for the doctors - Depression 3. Working with celebrities - Menopause4. Partnering with patients - Attention deficit disorder5. Making risks into medical conditions - High blood pressure 6. Advertising diseases: Premenstrual dysphoric disorder 7. Shaping public perceptions - Social anxiety disorder8. Testing the markets - Osteoporosis9. Taming the watchdogs - Irritable bowel syndrome10. Subverting the selling - Female sexual dysfunctionEpilogue - What can we do?
About the Author
Ray Moynihan has been covering the business of healthcare for almost a decade, first with the ABC and the Australian Financial Review, and more recently with the British Medical Journal, where he is a visiting editor. He is a regular contributor to the New England Journal of Medicine and Lancet and was a Harkness Fellow in health care policy based at Harvard University. His TV documentary on the selling of sickness was recently screened on SBS. Alan Cassels is a Canadian science writer.
|Publisher: ||Allen & Unwin|
|Dimensions: ||20.0 x 14.0 x 2.0 centimeters (0.31 kg)|